Log In
Print
BCIQ
Print
Print this Print this
 

PRI-724

  Manage Alerts
Collapse Summary General Information
Company Prism Pharma Co. Ltd.
DescriptionBeta-catenin (CTNNB1) inhibitor
Molecular Target Beta-catenin (CTNNB1)
Mechanism of ActionBeta-catenin antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today